Search
English

DNA Test

View as Grid List
Sort by
Display per page
Picture of DNA based early detection of Nasopharyngeal Carcinoma (NPC)

DNA based early detection of Nasopharyngeal Carcinoma (NPC)

The incidence rate of Nasopharyngeal Carcinoma (NPC) is remarkably high among Southeast Asia and Southern China regions, particularly Hong Kong. Therefore, it is also known as "Canton Tumor". Nasopharyngeal Carcinoma (NPC) does not have significant symptoms at preliminary stage, most of the patients would not be aware of the illness and have missed the optimal treatment period. In the early stage of Nasopharyngeal cancer, there are some similar symptoms with common cold, such as nose bleeding, headache, tinnitus, stuffiness, hearing loss, hoarseness and etc. It is reported that approximately 80% of the unscreened patients are in the advanced stage when the illness is diagnosed. There is no vaccine available against NPC at the moment, thus early screening will be the most effective means to raise early awareness, which could also increase the cure rate and survival rate.
HK$2,700.00 HK$1,988.00
Picture of Talent-PRO Gene Test (T48)

Talent-PRO Gene Test (T48)

Suitable for children at age of 0-12
HK$18,000.00
Picture of Talent-PRO Gene Test (T28)

Talent-PRO Gene Test (T28)

Suitable for children at age of 0-12
HK$10,000.00
Picture of Talent-PRO Gene Test (T10)

Talent-PRO Gene Test (T10)

Suitable for children at age of 0-12
HK$5,000.00
Picture of Circulating Tumor DNA (ctDNA) Early Cancer Risk Assessment (Male)

Circulating Tumor DNA (ctDNA) Early Cancer Risk Assessment (Male)

Suitable for people of all age group, especially those who exposure to radioactive environment frequently, multiple family members with same cancer type
HK$38,000.00
Picture of Circulating Tumor DNA (ctDNA) Early Cancer Risk Assessment (Female)

Circulating Tumor DNA (ctDNA) Early Cancer Risk Assessment (Female)

Suitable for people of all age group, especially those who exposure to radioactive environment frequently, multiple family members with same cancer type
HK$38,000.00